About GluSense
GluSense is a company based in Lod (Israel) founded in 2007. It operates as a B2B. GluSense has raised $26.9 million across 2 funding rounds from investors including ZTE, T1D Fund and Ping An Ventures. GluSense operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
- Headquarter Lod, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Glusense Ltd (Israel Company)
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.9 M (USD)
in 2 rounds
-
Latest Funding Round
$1.9 M (USD), Series A
Feb 15, 2017
-
Investors
ZTE
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GluSense
GluSense has successfully raised a total of $26.9M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.9 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GluSense
GluSense has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ZTE, T1D Fund and Ping An Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Companies developing T1D products are funded through venture philanthropy.
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for GluSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GluSense
Investment portfolio details for GluSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GluSense
Detailed financials for GluSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glusense Comparisons
Peer comparison for GluSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GluSense
GluSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| Locked | Locked | Locked |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
Detailed competitors of GluSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glusense
Complete news archive for GluSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GluSense
GluSense was founded in 2007 and raised its 1st funding round 8 years after it was founded.
GluSense is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
GluSense is a funded company, having raised a total of $26.9M across 2 funding rounds to date.
GluSense, established in 2007, excels in providing healthcare solutions, developing medical devices, diabetes management, and glucose monitoring. Develops implantable sensors for monitoring glucose levels in type 1 diabetes patients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
GluSense's top competitors include Dexcom, Senseonics and One Drop.
GluSense has 4 investors. Key investors include ZTE, T1D Fund, Ping An Ventures, and Yongjin Group.